- Home
- ARCT vs RGR Comparison
ARCT vs RGR Comparison
Compare ARCT & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- RGR
- Stock Information
- Founded
- ARCT 2013
- RGR 1949
- Country
- ARCT United States
- RGR United States
- Employees
- ARCT N/A
- RGR N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- RGR Ordnance And Accessories
- Sector
- ARCT Health Care
- RGR Industrials
- Exchange
- ARCT Nasdaq
- RGR Nasdaq
- Market Cap
- ARCT 320.8M
- RGR 553.4M
- IPO Year
- ARCT N/A
- RGR N/A
- Fundamental
- Price
- ARCT $18.09
- RGR $39.35
- Analyst Decision
- ARCT Strong Buy
- RGR
- Analyst Count
- ARCT 10
- RGR 0
- Target Price
- ARCT $50.88
- RGR N/A
- AVG Volume (30 Days)
- ARCT 499.7K
- RGR 186.8K
- Earning Date
- ARCT 11-06-2025
- RGR 10-29-2025
- Dividend Yield
- ARCT N/A
- RGR 1.78%
- EPS Growth
- ARCT N/A
- RGR N/A
- EPS
- ARCT N/A
- RGR 0.35
- Revenue
- ARCT $122,122,000.00
- RGR $536,291,000.00
- Revenue This Year
- ARCT N/A
- RGR N/A
- Revenue Next Year
- ARCT $28.92
- RGR $3.39
- P/E Ratio
- ARCT N/A
- RGR $113.79
- Revenue Growth
- ARCT N/A
- RGR 3.31
- 52 Week Low
- ARCT $8.04
- RGR $31.64
- 52 Week High
- ARCT $25.88
- RGR $42.76
- Technical
- Relative Strength Index (RSI)
- ARCT 53.17
- RGR 54.25
- Support Level
- ARCT N/A
- RGR N/A
- Resistance Level
- ARCT $18.69
- RGR $37.57
- Average True Range (ATR)
- ARCT 1.00
- RGR 0.85
- MACD
- ARCT -0.75
- RGR -0.93
- Stochastic Oscillator
- ARCT 92.77
- RGR 98.52
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.